Effectiveness of pegaspargase, gemcitabine, and oxaliplatin (P-GEMOX) chemotherapy combined with radiotherapy in newly diagnosed, stage IE to IIE, nasal-type, extranodal natural killer/T-cell lymphoma

A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis

(2016) Seok Jin Kim et al.   LANCET ONCOLOGY

Radiation dose reduction for patients with extranodal NK/T-cell lymphoma with complete response after initial induction chemotherapy

(2016) Liang Wang et al.   OncoTargets and Therapy

Risk stratification on the basis of Deauville score on PET-CT and the presence of Epstein-Barr virus DNA after completion of primary treatment for extranodal natural killer/T-cell lymphoma, nasal type: a multicentre, retrospective analysis

(2015) Seok Jin Kim et al.   Lancet Haematology

Ifosfamide, methotrexate, etoposide, and prednisolone (IMEP) plus l-asparaginase as a first-line therapy improves outcomes in stage III/IV NK/T cell-lymphoma, nasal type (NTCL)

(2014) Miso Kim et al.   ANNALS OF HEMATOLOGY

Effectiveness of gemcitabine, pegaspargase, cisplatin, and dexamethasone (DDGP) combination chemotherapy in the treatment of relapsed/refractory extranodal NK/T cell lymphoma: a retrospective study of 17 patients

(2014) Zhiyuan Zhou et al.   ANNALS OF HEMATOLOGY

Combination of gemcitabine, l-asparaginase, and oxaliplatin (GELOX) is superior to EPOCH or CHOP in the treatment of patients with stage IE/IIE extranodal natural killer/T cell lymphoma: a retrospective study in a cohort of 227 patients with long-term follow-up

(2014) Wang Liang et al.   MEDICAL ONCOLOGY

How I treat NK/T-cell lymphomas

(2013) E. Tse et al.   BLOOD

A phase I/II trial of bortezomib combined concurrently with gemcitabine for relapsed or refractory DLBCL and peripheral T-cell lymphomas

(2013) Andrew M. Evens et al.   BRITISH JOURNAL OF HAEMATOLOGY

Rituximab plus gemcitabine and oxaliplatin in patients with refractory/relapsed diffuse large B-cell lymphoma who are not candidates for high-dose therapy. A phase II Lymphoma Study Association trial

(2013) N. Mounier et al.   HAEMATOLOGICA

Combined therapy in untreated patients improves outcome in Nasal NK/T lymphoma: results of a clinical trial

(2013) Agustin Avilés et al.   MEDICAL ONCOLOGY

SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group

(2012) Y.-L. Kwong et al.   BLOOD

First-line combination of gemcitabine, oxaliplatin, and L-asparaginase (GELOX) followed by involved-field radiation therapy for patients with stage IE/IIE extranodal natural killer/T-cell lymphoma

(2012) Liang Wang et al.   CANCER

Prospective measurement of Epstein-Barr virus-DNA in plasma and peripheral blood mononuclear cells of extranodal NK/T-cell lymphoma, nasal type

(2011) R. Suzuki et al.   BLOOD

Phase 2 trial of “Sandwich”L-asparaginase, vincristine, and prednisone chemotherapy with radiotherapy in newly diagnosed, stage IE to IIE, nasal type, extranodal natural killer/T-cell lymphoma

(2011) Ming Jiang et al.   CANCER

Phase II Study of SMILE Chemotherapy for Newly Diagnosed Stage IV, Relapsed, or Refractory Extranodal Natural Killer (NK)/T-Cell Lymphoma, Nasal Type: The NK-Cell Tumor Study Group Study

(2011) Motoko Yamaguchi et al.   JOURNAL OF CLINICAL ONCOLOGY

Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study

(2010) A. Jaccard et al.   BLOOD

Gemcitabine as single agent in pretreated T-cell lymphoma patients: evaluation of the long-term outcome

(2009) P. L. Zinzani et al.   ANNALS OF ONCOLOGY

Phase I/II Study of Concurrent Chemoradiotherapy for Localized Nasal Natural Killer/T-Cell Lymphoma: Japan Clinical Oncology Group Study JCOG0211

(2009) Motoko Yamaguchi et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase II Trial of Concurrent Radiation and Weekly Cisplatin Followed by VIPD Chemotherapy in Newly Diagnosed, Stage IE to IIE, Nasal, Extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma Study

(2009) Seok Jin Kim et al.   JOURNAL OF CLINICAL ONCOLOGY

Immunohistochemical expression and clinical significance of P-glycoprotein in previously untreated extranodal NK/T-cell lymphoma, nasal type

(2008) Biyun Wang et al.   AMERICAN JOURNAL OF HEMATOLOGY

A Clinical Study of 115 Patients with Extranodal Natural Killer/T-cell Lymphoma, Nasal Type

(2008) X. Wu et al.   CLINICAL ONCOLOGY

Early or Up-Front Radiotherapy Improved Survival of Localized Extranodal NK/T-Cell Lymphoma, Nasal-Type in the Upper Aerodigestive Tract

(2007) Mei-juan Huang et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: Elucidating the significance of systemic chemotherapy

(2007) Ye Guo et al.   ORAL ONCOLOGY